Lung Cancer
A Phase II single-arm trial to investigate tepotinib inadvanced (Stage IIIB/IV) non-small cell lung cancerwith MET exon 14 (METex14) skipping alterations or MET amplification(VISION): MS200095-0022
- Details
ClinicalTrials.gov ID:
NCT02864992
Diagnosis Type:
NSCLC
USOR Number:
- Address
4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302